Literature DB >> 14524420

Persistent mammary hyperplasia in FVB/N mice.

Ana I Nieto1, G Shyamala, Jose J Galvez, Gudmundur Thordarson, Lalage M Wakefield, Robert D Cardiff.   

Abstract

The inbred FVB/N mouse strain is widely used for creating transgenic mice. Over the past decade, persistent mammary hyperplasia has been detected in many multiparous FVB/N female mice sent to the University of California, Davis (UCD) Mutant Mouse Pathology Laboratory (MMPL) by a number of different laboratories. However, the experimental details concerning most specimens were not always available. To confirm these empiric findings, experiments were carried out to evaluate the mammary glands of FVB/N mice under controlled conditions. Persistent mammary hyperplasia that related to parity was found. Weeks after their first to fourth pregnancy, 10 FVB/N female mice from the Lawrence Berkeley National Laboratory (LBNL) colony were studied and the mammary glands were evaluated. The percentage of fat pad filled was estimated, using image analysis. Serum samples and the pituitary gland from other FVB/N mice from the LBNL were assayed for prolactin concentration. Multiparous FVB/N females consistently had persistent mammary hyperplasia. Four of seven females in the LBNL colony had hyperplasia after three pregnancies. A few foci of squamous nodules and sporadic carcinomas also were observed. Thus, some FVB/N females may have persistent mammary hyperplasia after three pregnancies without detectable pituitary abnormalities. Mammary carcinomas also may develop sporadically. These background phenotypes must be considered when interpreting the effect of genetic manipulation in FVB/N mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14524420

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  16 in total

1.  Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer.

Authors:  Kristen Weber Lozada; Ruth A Keri
Journal:  Biol Reprod       Date:  2011-06-02       Impact factor: 4.285

Review 2.  The genomic revolution and endocrine pathology.

Authors:  Suzana S Couto; Robert D Cardiff
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

3.  Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.

Authors:  Carrie R Graveel; Jack D DeGroot; Yanli Su; Julie Koeman; Karl Dykema; Samuel Leung; Jacqueline Snider; Sherri R Davies; Pamela J Swiatek; Sandra Cottingham; Mark A Watson; Matthew J Ellis; Robert E Sigler; Kyle A Furge; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-30       Impact factor: 11.205

4.  Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.

Authors:  Youping Sun; Luigi Strizzi; Ahmed Raafat; Morihisa Hirota; Caterina Bianco; Lionel Feigenbaum; Nicholas Kenney; Christian Wechselberger; Robert Callahan; David S Salomon
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.

Authors:  Gordana Maric; Matthew G Annis; Patricia A MacDonald; Caterina Russo; Dru Perkins; Doris R Siwak; Gordon B Mills; Peter M Siegel
Journal:  Oncogene       Date:  2019-03-26       Impact factor: 9.867

6.  CrkII transgene induces atypical mammary gland development and tumorigenesis.

Authors:  Kelly E Fathers; Sonia Rodrigues; Dongmei Zuo; Indrani Vasudeva Murthy; Michael Hallett; Robert Cardiff; Morag Park
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  Germline met mutations in mice reveal mutation- and background-associated differences in tumor profiles.

Authors:  Carrie R Graveel; Jack D DeGroot; Robert E Sigler; George F Vande Woude
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

8.  Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice.

Authors:  Peigen Huang; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 9.  Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression.

Authors:  Kay-Uwe Wagner; Hallgeir Rui
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-29       Impact factor: 2.673

10.  Sequencing and characterization of the FVB/NJ mouse genome.

Authors:  Kim Wong; Suzannah Bumpstead; Louise Van Der Weyden; Laura G Reinholdt; Laurens G Wilming; David J Adams; Thomas M Keane
Journal:  Genome Biol       Date:  2012-08-23       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.